HedgeCo.Net — Castelion announced a $1 billion Series C on August 19. The company described the round as $800 million of equity financing plus $250 million of committed financing for a revolving credit facility, and said the equity values the Torrance, California defense manufacturer at $13 billion. SpaceNews independently reported the same split, co-leads, and $13 billion mark. Do not read $1 billion as all equity. Eight hundred million is the equity check. Two hundred fifty million is committed revolver capacity.
JPMorganChase’s Strategic Investment Group, part of the bank’s Security and Resiliency Initiative, co-led the equity with Andreessen Horowitz and funds managed by Carlyle. Lightspeed, Lavrock Ventures, Altimeter, General Catalyst, and Interlagos participated. T. Rowe Price Associates joined as a new investor, through an account it advises. Proceeds are aimed at higher-rate production of Blackbeard, Castelion’s first hypersonic strike missile, plus a longer-range strike system and defensive weapons.
The operating facts that are dual-sourced sit next to the capital structure. Castelion said it has secured more than $500 million in U.S. military contracts over the past 18 months and is targeting fielding in 2027. SpaceNews repeated both figures and noted a Pentagon framework that contemplates a minimum production rate of 500 missiles a year after testing and validation. That framework is not a production close. Blackbeard still needs integration, flight test, and certification.
For venture and growth LPs the diligence is the mix of equity, contract coverage, and factory spend. Carlyle’s aerospace, defense, and government team sitting next to a16z and a bank strategic is a different syndicate than a pure seed-to-C venture ladder. The $13 billion post-money is the company’s stated mark. It is not a public-market print and not a government offtake.
The second-order read is how defense-tech vintages are now being financed: a large equity round, a committed revolver, and a manufacturing campus, not a software multiple. Allocators should keep the $800 million and the $250 million on separate lines, treat the $13 billion as a private mark, and wait for fielding rather than mark a Series C as a munitions book.